Track record
James E Flynn
An officer, director or large holder of 7 blank-check companies. Every role below was declared by James E Flynn in an SEC ownership filing.
Vehicles
7
Still live
0
Closed a deal
6 of 7
Capital involved
$775M
Every vehicle, newest first
- DA32 Life Science Tech Acquisition Corp.— · Director · IPO Jul 29, 2021$204MLiquidated
- Peak Bio, Inc.— · 10% holder · IPO Jan 28, 2021$57.8MCompleted
- Frazier Lifesciences Acquisition Corp— · 10% holder · IPO Dec 10, 2020$139MCompleted
- CareMax, Inc.— · Director · IPO Jul 20, 2020$144MCompleted
- Starling Oncology, Inc.STLN · Director · IPO Mar 12, 2020$230MCompleted
- Tessera Defense & Homeland Security Inc.HLSQ · Director · IPO Dec 15, 2018Completed
- AdaptHealth Corp.AHCO · Director · IPO Feb 15, 2018Completed
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1352546. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.